Cipla (LUX:CIPLA) Interest Received


LUX:CIPLA Cipla Ltd LUX:CIPLA
95 GF Score
Price $18.10
GF Value $19.80
! 5 Warning Signs
View Full Analysis

What is Cipla Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

LUX:CIPLA
95GF Score
Cipla Ltd LUX:CIPLA
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cipla (LUX:CIPLA) Overvalued in 2026?

Based on GuruFocus' analysis, Cipla stock appears to be undervalued. The current stock price of $18.10 is trading 8.6% below its estimated GF Value™ of $19.80.

Key valuation signals for LUX:CIPLA:

  • Interest Received:
  • GF Value™: $19.80 vs. price of $18.10 (8.6% below fair value)
  • GF Score™: 95/100 with 5 warning signs

No single metric tells the full story. See the LUX:CIPLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cipla Business Description

Other Exchanges CIPLA:India500087:India
Address Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.
95GF Score

Get the complete analysis for LUX:CIPLA

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.10
Price
$19.80
GF Value